Delivery Order SPE2DB20D1100-SPE2DB24FC4J9
Award Date
6/25/24
Potential Completion Date
6/26/24
Potential Value
$6.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,054.62 firm fixed-price delivery order is for the pharmaceutical product ZORYVE 0.3% Cream, 60 GM. The contract has a period of performance through February 6, 2025 and was awarded on February 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,012.77, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564362240 ZORYVE 0.3% Cream 60GM, a pharmaceutical product, over a period ending on April 23, 2024. Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation, holds a significant Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The contract, valued at up to $1,084.84, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX5JN, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZORYVE 0.3% CREAM 60GM, a medical product, with a ceiling value of $6,712.54 and a completion date of November 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,294.33 firm fixed-price delivery order covers the supply of ZORYVE 0.3% Cream, a pharmaceutical product, with a period of performance through April 5, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The contract is a delivery order valued at $9,292.68 for the supply of the pharmaceutical product ZORYVE 0.3% Cream 60GM. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Zoryve 0.3% cream in a 60 gram package. The $1,084.84 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 21, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,130.98 firm fixed-price delivery order covers the supply of ZORYVE 0.3% Cream, a pharmaceutical product, to support federal healthcare programs. The contract is not designated with a set-aside requirement, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4564016231 - ZORYVE 0.3% CREAM 60GM. The firm-fixed-price delivery order has a ceiling value of $3,314.21 and a completion date of March 20, 2024. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides medical products and supplies to federal government agencies, particularly the DLA Troop...
This federal contract award, with the ID SPE2DX15D3020|SPE2DX25FPXTM, was granted to AmerisourceBergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,461.96 firm fixed-price delivery order is for the supply of the pharmaceutical product ZORYVE 0.3% Cream, 60GM. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the agency to...